Cargando…
A review of adjuvants for Leishmania vaccine candidates
Over the last decade, there has been a flurry of research on adjuvants for vaccines, and several novel adjuvants are now licensed products or in late stage clinical development. The success of adjuvants in enhancing the immune response to antigens has led many researchers to re-focus their vaccine d...
Autores principales: | Mutiso, Joshua M., Macharia, John C., Gicheru, Michael M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596531/ https://www.ncbi.nlm.nih.gov/pubmed/23554607 http://dx.doi.org/10.1016/S1674-8301(10)60004-8 |
Ejemplares similares
-
Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops)()
por: Mutiso, Joshua Muli, et al.
Publicado: (2012) -
Development of Leishmania vaccines: predicting the future from past and present experience
por: Mutiso, Joshua Muli, et al.
Publicado: (2013) -
In vitro activity and in vivo efficacy of a combination therapy of diminazene and chloroquine against murine visceral leishmaniasis
por: Mwololo, Samuel W, et al.
Publicado: (2015) -
Experimental therapeutic studies of Solanum aculeastrum Dunal. on Leishmania major infection in BALB/c mice
por: Laban, Linet T, et al.
Publicado: (2015) -
Safety and Efficacy of Prosopis juliflora Leaf Extract as a Potential Treatment against Visceral Leishmaniasis in Balb/c Mice
por: Mutile, Muendo Charity, et al.
Publicado: (2021)